$2.28T
Total marketcap
$105.33B
Total volume
BTC 49.91%     ETH 15.49%
Dominance

FusionPharm FSPM Stock

0.0001 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
1.06K USD
LOW - HIGH [24H]
0.0001 - 0.0001 USD
VOLUME [24H]
1 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.147 USD

FusionPharm Price Chart

FusionPharm FSPM Financial and Trading Overview

FusionPharm stock price 0.0001 USD
Previous Close 0.0002 USD
Open 0.0002 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.0002 - 0.0002 USD
52 Week Range 0.0001 - 0.0002 USD
Volume 1 USD
Avg. Volume 1.14K USD
Market Cap 2.12K USD
Beta (5Y Monthly) -12.809859
PE Ratio (TTM) N/A
EPS (TTM) -0.147 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

FSPM Valuation Measures

Enterprise Value 294.87K USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.0064436635
Price/Book (mrq) N/A
Enterprise Value/Revenue 0.897
Enterprise Value/EBITDA N/A

Trading Information

FusionPharm Stock Price History

Beta (5Y Monthly) -12.809859
52-Week Change 100.00%
S&P500 52-Week Change 20.43%
52 Week High 0.0002 USD
52 Week Low 0.0001 USD
50-Day Moving Average 0.000168 USD
200-Day Moving Average 0.000149 USD

FSPM Share Statistics

Avg. Volume (3 month) 1.14K USD
Avg. Daily Volume (10-Days) 1.9K USD
Shares Outstanding 10.59M
Float N/A
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor 1:200

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2011
Most Recent Quarter (mrq) March 31, 2012
Next Fiscal Year End December 31, 2012

Profitability

Profit Margin -110.71%
Operating Margin (ttm) -110.82%
Gross Margin 20.38%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -137.68%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 328.7K USD
Revenue Per Share (ttm) 0.13 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 34.19K USD
EBITDA N/A
Net Income Avi to Common (ttm) -363930 USD
Diluted EPS (ttm) -0.147
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.45K USD
Total Cash Per Share (mrq) 0.001 USD
Total Debt (mrq) 295.7K USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.733
Book Value Per Share (mrq) -0.067

Cash Flow Statement

Operating Cash Flow (ttm) -286511 USD
Levered Free Cash Flow (ttm) -254215 USD

Profile of FusionPharm

Country United States
State CO
City Commerce City
Address 5850 East 58th Avenue
ZIP 80022
Phone 720-458-0686
Website https://www.fusionpharminc.com
Industry Pharmaceutical Retailers
Sector(s) Healthcare
Full Time Employees 4

FusionPharm, Inc. develops, manufactures, and sells a line of cultivation containers under the PharmPod brand name in the United States. Its PharmPods cultivation container system is used in the indoor plant cultivation. The company also offers its products to businesses, universities, and individuals to cultivate various plants. FusionPharm, Inc. was formerly known as Baby Bee Bright Corp. and changed its name to FusionPharm, Inc. in April 2011. The company was founded in 1998 and is based in Commerce City, Colorado.

Q&A For FusionPharm Stock

What is a current FSPM stock price?

FusionPharm FSPM stock price today per share is 0.0001 USD.

How to purchase FusionPharm stock?

You can buy FSPM shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for FusionPharm?

The stock symbol or ticker of FusionPharm is FSPM.

Which industry does the FusionPharm company belong to?

The FusionPharm industry is Pharmaceutical Retailers.

How many shares does FusionPharm have in circulation?

The max supply of FusionPharm shares is 10.59M.

What is FusionPharm Price to Earnings Ratio (PE Ratio)?

FusionPharm PE Ratio is now.

What was FusionPharm earnings per share over the trailing 12 months (TTM)?

FusionPharm EPS is -0.147 USD over the trailing 12 months.

Which sector does the FusionPharm company belong to?

The FusionPharm sector is Healthcare.